Meetings of the Minds 2004 | Research & Development | SENJU Pharmaceutical

Meetings of the Minds2004

XVI International Congress of Eye Research

  • DAY: to be released
  • Place:Sydney, Australia
  • Calpain-specific proteolysis in monkey retina
  • Emi Nakajima1,2, Michael A. Riviere2, Yoshiyuki Tamada1, Larry L. David2 Nakajima1, Mitsuyoshi Azuma1,2 and Thomas R. Shearer2
    1 Senju Pharmaceutical Co. Ltd., 2 Oregon Health & Science University

The Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting

  • DAY: to be released
  • Place:Fort Lauderdale, Florida, U.S.A.
  • ①Involvement of cyclooxygenase-2 in rat models of anterior ocular inflammation
    ②Involvement of Egr-1 in lens epithelial cell death induced by selenite
    ③Regeneration of Retinal Ganglion Cells Induced by suppression of Rho-Associated Protein Kinase
    ④Calpain-induced proteolysis in lens epithelial cell death during ovine inherited cataract
  • ①M.Azuma1, T.Oka1, T.R. Shearer2
     1Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR.
    ②T. Nakajima1, P.B. Belusko1, R. Walkup1, M. Azuma1, T.R. Shearer2
     1Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR.
    ③Y.Takayama1, C.Fukiage1, H.Tokushige1, Y.Yoshida1, M.Azuma1, M.Uehata2
     1Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Discovery Technology Laboratory, Mitsubishi Pharma Corporation, Yokohama, Japan.
    ④L.J. G. Robertson1, E.Nakajima2, J.D. Morton1, L.L. David3,  T.R. Shearer3, M.Azuma2
     1Animal & Food Sciences Division, Lincoln University, Christchurch, New Zealand; 2Senju Pharmaceutical, Beaverton, OR; 3Integrative Biosciences, Oregon Health & Sciences University, Portland, OR.

() () () ()

5th International Symposium on Ocular Pharmacology and Therapeutics (5th ISOPT)

  • DAY: to be released
  • Place:Monte Carlo, MONACO

・TAU-284
 Safety and efficacy of topical bepotastine besilate in conjunctival allergen challenge model
 T. Sekiya
・SJE-2079
 Safety and efficacy of topical difluprednate in patients with severe anterior uveitis
 T. Ogawa
・TimolastTM
 Ocular hypotensive effect of a new “once-daily” eye-drops formulation of 0.5% timolol (TimolastTM) in comparison to TimoptolTM 0.5% administered twice-daily : A 4-month multicenter cross-over clinical trial
 J. F. Rouland, ....

US-JAPAN Cooperative Cataract Research Group Meeting

  • DAY: to be released
  • Place:Kona, Hawaii, USA
  • The activation and regulation of lens-specific calpain Lp82 in rodent lens
  • C. Fukiage, M. Azuma and T.R. Shearer

new | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999